Literature DB >> 21996560

The successful remission induction by sorafenib and long-term complete remission in a FLT3-ITD-positive patient with a refractory acute erythroid leukemia and abnormal cytogenetics.

Masanori Mori, Julian Sprague.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21996560     DOI: 10.1016/j.leukres.2011.09.023

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  2 in total

Review 1.  Precision therapy for acute myeloid leukemia.

Authors:  Xue Yang; Jianxiang Wang
Journal:  J Hematol Oncol       Date:  2018-01-05       Impact factor: 17.388

2.  Prognosis and outcome of patients with acute myeloid leukemia based on FLT3-ITD mutation with or without additional abnormal cytogenetics.

Authors:  Shandong Tao; Chunling Wang; Yue Chen; Yuan Deng; Lixiao Song; Yuyue Shi; Lanlan Ling; Banghe Ding; Zhengmei He; Liang Yu
Journal:  Oncol Lett       Date:  2019-11-05       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.